On May 25, 2023, Clive Meanwell, the Director at Invivyd, was granted stock options that amount to 50,000 shares of IVVD. The options allow Meanwell to purchase the company’s stock at a rate of $1.7 per share. As a result, his shares are currently valued at $69,950. It is worth noting that Invivyd operates in the Health Care sector.
Insider transactions such as this one can provide insight into the insider’s expectations for the stock’s future performance. However, it is important to remember that insider transactions should not be the sole basis for making investment decisions. Instead, investors should focus on transactions that occur in the open market, which are indicated in Table I of the Form 4 filing. In this table, a P in Box 3 denotes a purchase, while an S indicates a sale.
IVVD Stock: Health Technology Company in Biotechnology Industry with Upcoming Reporting Date and EPS Forecast
On May 26, 2023, IVVD stock opened at 1.44, a decrease from its previous close of 1.47. The day’s range was between 1.40 and 1.49, with a volume of 2,838 shares traded. The market cap for IVVD was $135.8M.
IVVD is a company in the Health Technology sector, specifically in the Biotechnology industry.
In terms of earnings growth, IVVD had a negative growth of -8.88% last year, but has seen a positive growth of +31.84% this year. There is no available data on earnings growth for the next five years. The company did not report any revenue growth for the past year.
IVVD’s P/E ratio is not available, and there is no data on its price/sales ratio. The price/book ratio is 0.38. The next reporting date for IVVD is September 18, 2023. The EPS forecast for this quarter is -$0.37.
In terms of financial performance, IVVD had an annual revenue of $0.00 and an annual profit of -$241.3M last year. There is no data available on the net profit margin.
Investors should keep an eye on IVVD’s upcoming reporting date and EPS forecast for this quarter to gauge the company’s financial health.
Invivyd Incs Stock Analysis: Median Target Price, Earnings, and Sales
On May 26, 2023, Invivyd Inc’s stock (IVVD) had a median target price of 1.50, according to three analysts offering 12-month price forecasts. The high estimate was 5.00, and the low estimate was 1.00. The median estimate represented a +2.04% increase from the last price of 1.47. The consensus among four polled investment analysts was to hold stock in Invivyd Inc. This rating had held steady since April. Invivyd Inc’s earnings per share for the current quarter were -$0.37, and the sales were $0.00. The reporting date for this information was September 18, 2023. Investors should keep an eye on Invivyd Inc’s financial performance in the coming quarters to determine whether the company is a good investment opportunity.
Discussion about this post